Physician profile
Cuong Ha
NPI 1962499061
$371.23
in general payments reported to CMS, 2019-2025
7 companies · $16.66 in 2025
The $16.66 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.62 · 2020: $33.24 · 2021: $21.60 · 2022: $13.72 · 2023: $147 · 2024: $67.19 · 2025: $16.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131 · Education: $99.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.30 |
| Education | $99.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $113.71 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $99.75 | 2023 | Sotyktu |
| Galderma Laboratories, L.P. | $62.08 | 2019-2024 | |
| Arcutis Biotherapeutics, INC. | $29.95 | 2024-2025 | Zoryve |
| Lilly USA, LLC | $27.62 | 2023 | Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $24.40 | 2019 | |
| Janssen Biotech, INC. | $13.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cuong Ha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.